Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014241A2 Compositions and methods for the treatment of immune related diseases
03/25/1999WO1999014240A1 Interleukin-17 receptor-like protein
03/25/1999WO1999014239A1 Composition for treating diabetes mellitus and obesity
03/25/1999WO1999014238A1 Process for the preparation of calcitonin
03/25/1999WO1999014237A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999WO1999014236A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
03/25/1999WO1999014235A1 Persephin and related growth factors
03/25/1999WO1999014234A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/25/1999WO1999014233A1 Peptides derived from cowdria ruminantium, antibodies thereto and their diagnostical and medical uses
03/25/1999WO1999014232A1 A peptide with an affinity for clotting factor viii
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014230A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999WO1999014189A1 Amino acid derivatives
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013905A1 Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
03/25/1999WO1999013899A1 Peptides and peptidomimetics for inhibiting complement activation
03/25/1999WO1999013898A1 EC-3, AN INHIBITOR OF α4β1 AND α4β7 INTEGRINS
03/25/1999WO1999013897A1 Prevention of pregnancy miscarriages
03/25/1999WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999WO1999013895A1 Polypeptide compositions that inhibit potassium channel activity and uses therefor
03/25/1999WO1999013818A2 Membrane virus host range mutations and their uses as vaccine substrates
03/25/1999WO1999013726A1 Neuronal cells and an immunosuppressant and anti-inflammatory factor
03/25/1999WO1999013720A1 Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
03/25/1999WO1999013719A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999WO1999013710A1 A method of treatment and an animal model useful for same
03/25/1999WO1999004825A8 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
03/25/1999WO1999003985B1 Glutenin genes and their uses
03/25/1999WO1999002554A3 Human herpesvirus-7 diagnostic and immunologic reagents and use thereof
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999WO1998058068A3 A method for plant protection against insects or nematodes
03/25/1999WO1998057994A3 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/25/1999WO1998056813A3 Two human membrane-fusion proteins
03/25/1999WO1998055509A3 Two human dnaj-like proteins
03/25/1999WO1998055508A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
03/25/1999WO1998054328A3 Genes controlling floral development and apical dominance in plants
03/25/1999WO1998054225A3 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
03/25/1999WO1998053061A9 Three novel genes encoding a zinc finger protein, a guanine, nucleotide exchange factor and a heat shock protein or heat shock binding protein
03/25/1999WO1998052970A9 Vif-derived hiv protease inhibitors
03/25/1999WO1998051780A3 Method for increasing yields or recombinant proteins
03/25/1999WO1998050068A9 Mass spectrometry of colonization factors
03/25/1999WO1998049268A9 Natural killer cell lines and methods of use
03/25/1999WO1998048011A9 Novel chimeric molecules
03/25/1999WO1998047916A9 Bifunctional polypeptides for cell-specific viral targeting
03/25/1999WO1998042296A3 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
03/25/1999DE19741607A1 New polypeptides comprising prion protein sequences
03/25/1999CA2382506A1 Novel polypeptides and nucleic acids encoding pro293 which are useful for treating disorders of the pancreas
03/25/1999CA2382495A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382409A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304368A1 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
03/25/1999CA2304349A1 The porcine adipocyte fatty acid-binding protein encoding gene and methods to localise, identify or mark genes or alleles or quantitative trait loci of farm animals
03/25/1999CA2304256A1 Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
03/25/1999CA2304205A1 Prevention of pregnancy miscarriages
03/25/1999CA2304167A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999CA2304132A1 A method of treatment and an animal model useful for same
03/25/1999CA2304128A1 Improved method of production of pneumococcal surface proteins
03/25/1999CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999CA2304124A1 Bci-2-like protein bim and methods of use thereof
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303908A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303759A1 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999CA2303397A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/25/1999CA2303002A1 Mammalian genes participating in circadian period
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2302434A1 Yeast strains for the production of lactic acid
03/25/1999CA2296045A1 Persephin and related growth factors
03/25/1999CA2271716A1 Plant-origin regulator protein and nucleic acid encoding the same
03/25/1999CA2244971A1 Mure
03/25/1999CA2244967A1 Murf
03/24/1999EP0903408A2 Tat-derived transport polypeptide
03/24/1999EP0903407A2 Streptococcus pneumoniae phoH gene
03/24/1999EP0903406A1 Modulation of gene expression through interference with RNA secondary structure
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0903149A1 Method of screening apoptosis inducing substances
03/24/1999EP0903147A2 Use of REG-2 as a Schwann cell mitogen
03/24/1999EP0902837A1 Tailless nuclear hormone receptor (tlx receptor)
03/24/1999EP0902834A1 Stable avidin composition and methods using same
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0788512B1 Proinsulin peptide compounds for detecting and treating type i diabetes
03/24/1999EP0746569A4 Receptor-binding determinant from leukaemia inhibitory factor
03/24/1999EP0739413B1 Method of selecting specific bacteriophages
03/24/1999EP0705346B1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof
03/24/1999EP0664786B1 Arginine keto-amide enzyme inhibitors
03/24/1999EP0589995B1 Novel polypeptides and their use
03/24/1999EP0534978B1 Interleukin-1 antagonist and uses thereof
03/24/1999CN1212017A Hybrid proteins which form heterodimers
03/24/1999CN1212016A Recombinant ribonuclease proteins
03/24/1999CN1212014A Method for controlling water content of plant
03/24/1999CN1211991A Compounds with growth hormone releasing properties
03/24/1999CN1211924A Immunomodulatory complex for helicobacter bacteria
03/24/1999CN1211918A TNF－α转变酶 TNF-α converting enzyme
03/24/1999CN1211619A Novel protein having aspartase activity and gene DNA coding for the same
03/24/1999CN1211578A PEG-inerferon conjugates
03/23/1999US5886163 A recombinant nucleic acid molecule which encodes a mutant hiv-1 gp120 envelope glycoprotein comprising a v3 loop deletion and a c4 domains.sub.(w.fwdarw.x) point mutation, wherein x is an amino acid residue other than tryptophan
03/23/1999US5886156 A complex of tri or teterapeptide covalently linked to the peptide either directly or through a linker and lipid or mixture of lipids; useful in treatment of respiratory distress syndrome
03/23/1999US5886155 Preparing miracle fruit extract; combining extract in the presence of an equilibration buffer with a hydrophobic interaction chromatography medium of hydrophobicity sufficiently high to bind polyphenols, passing through column
03/23/1999US5886153 Antibodies directed against the alpha interferon receptor
1 ... 2298 2299 2300 2301 2302 2303 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 ... 2916